webleads-tracker

Pharma Compliance Info Life After Transparency Reporting – What’s Next? Global

Life After Transparency Reporting – What’s Next?

Several clients have asked me lately what they should start focusing on after transparency reporting, and my answer is that setting up a process for collecting spend information was just the beginning. The next phase should focus on making sure the processes are accurate and efficient, and how to get the maximum value out of the aggregate spend information.Pharma Compliance Info Life After Transparency Reporting – What’s Next? Global
In this article I have identified five areas that companies are focusing on after they have their aggregate spend system up and running.
1. Validation of reporting information
2. Automation of spend collection processes
3. Fair Market Value (FMV), Key Opinion Leader (KOL) scoring, background screening
4. Third party validation and background screening
5. Data analysis of reporting information capability
Albeit painful and costly to implement, aggregate spend is starting to provide us with more insight into our own and our competitor’s businesses. In addition, this information and insight is allowing us to optimize our processes and business practices. Companies have started to embrace the collection of the data and Sales, Marketing and Medical are starting to ask for the collection of additional information, providing additional insights.
To read this article by Andy Bender, President and Founder of Polaris Management

Check Also

Pharma Compliance Info Canada | More Transparency In Health Care: Ontario's Proposed "Sunshine" Legislation Global

Canada | More Transparency In Health Care: Ontario’s Proposed “Sunshine” Legislation

The Ontario Government introduced a bill on September 27 to enact legislation aimed at strengthening …

X